Pharmacogenomics has gained enormous popularity in recent years and is spearheading progress in precision medicine. This partnership highlights our commitment to improving healthcare through precision medicine.” Peter Dansky, president of Agena Bioscience, expressed enthusiasm about this development, stating, “As a leading provider of PGx testing tools, we are proud to work with Manchester University to provide unique offerings that address our customers’ desire to increase their knowledge and proficiency in pharmacogenomics. “We are thrilled to partner with Agena Bioscience, an industry leader in the PGx space, to offer our programmes to a broader audience.” Thomas Smith, Pharm.D., J.D., Dean of Pharmacy and Graduate Life Sciences at Manchester University. Our educational programs are aimed at producing applied scientists with opportunities for careers in the PGx laboratory industry, translational companies, and healthcare systems,” stated W. We believe that pharmacogenomics will increasingly enable physicians and other clinicians to prescribe the right dose of the right medicine at the right time, which ultimately leads to better healthcare outcomes. “Our relationship with Agena stems from the mutual goal of expanding the awareness of pharmacogenetic testing and its importance to the future of precision medicine. The MU Master of Science in PGx programme provides unparalleled depth and breadth in pharmacogenomics, covering human genetics, bioinformatics, pharmacokinetics, and more. The PGx Graduate Certificate is comprised of five courses aimed at providing in-depth education to enhance the clinical capabilities of health care professionals. Both programmes are fully online and delivered by Manchester University faculty. This partnership will enable Agena Bioscience to promote and offer its customers the established MU PGx programmes, including the Graduate Certificate in PGx or Master of Science in PGx degree. MU is a leading institution providing innovative pharmacogenomic (PGx) educational programmes within healthcare and laboratory sciences. Wednesday, December 1, 2021, 14:00 Hrs Īgena Bioscience (part of Mesa Labs’ Clinical Genomics Division), a global provider of genetic testing solutions, announced a partnership with Manchester University (MU) to expand awareness and access to PGx educational resources. Agena Bioscience, Manchester University partner to provide educational resources to pharmacogenomics industry
0 kommentar(er)
